Metabolic Drivers of Invasion in Glioblastoma

被引:51
作者
Garcia, Joseph H. [1 ]
Jain, Saket [1 ]
Aghi, Manish K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
glioblastoma; invasion; brain tumor; metabolism; microenvironment; PENTOSE-PHOSPHATE PATHWAY; BRAIN EXTRACELLULAR-MATRIX; KETOGENIC DIET; STEM-CELLS; MALIGNANT GLIOMAS; TUMOR METABOLISM; LIPID-METABOLISM; BREAST-CANCER; EMERGING ROLE; IMMUNE CELLS;
D O I
10.3389/fcell.2021.683276
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glioblastoma is a primary malignant brain tumor with a median survival under 2 years. The poor prognosis glioblastoma caries is largely due to cellular invasion, which enables escape from resection, and drives inevitable recurrence. While most studies to date have focused on pathways that enhance the invasiveness of tumor cells in the brain microenvironment as the primary driving forces behind GBM's ability to invade adjacent tissues, more recent studies have identified a role for adaptations in cellular metabolism in GBM invasion. Metabolic reprogramming allows invasive cells to generate the energy necessary for colonizing surrounding brain tissue and adapt to new microenvironments with unique nutrient and oxygen availability. Historically, enhanced glycolysis, even in the presence of oxygen (the Warburg effect) has dominated glioblastoma research with respect to tumor metabolism. More recent global profiling experiments, however, have identified roles for lipid, amino acid, and nucleotide metabolism in tumor growth and invasion. A thorough understanding of the metabolic traits that define invasive GBM cells may provide novel therapeutic targets for this devastating disease. In this review, we focus on metabolic alterations that have been characterized in glioblastoma, the dynamic nature of tumor metabolism and how it is shaped by interaction with the brain microenvironment, and how metabolic reprogramming generates vulnerabilities that may be ripe for exploitation.
引用
收藏
页数:16
相关论文
共 178 条
[1]  
Agarwal P, 2017, AM J CANCER RES, V7, P1990
[2]   MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review [J].
Ahir, Bhavesh K. ;
Ozer, Howard ;
Engelhard, Herbert H. ;
Lakka, Sajani S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 :22-33
[3]   Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma [J].
Ahmad, Fahim ;
Sun, Qian ;
Patel, Deven ;
Stommel, Jayne M. .
CANCERS, 2019, 11 (02)
[4]  
Alberts B.J.A., 2002, Molecular Biology of the Cell, Vfourth
[5]   Cholesterol: An Achilles' Heel for Glioblastoma? [J].
An, Zhenyi ;
Weise, William A. .
CANCER CELL, 2016, 30 (05) :653-654
[6]   The emerging role and targetability of the TCA cycle in cancer metabolism [J].
Anderson, Nicole M. ;
Mucka, Patrick ;
Kern, Joseph G. ;
Feng, Hui .
PROTEIN & CELL, 2018, 9 (02) :216-237
[7]   Endothelial PKCα-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes? [J].
Anfuso, Carmelina Daniela ;
Motta, Carla ;
Giurdanella, Giovanni ;
Arena, Valeria ;
Alberghina, Mario ;
Lupo, Gabriella .
BIOCHIMIE, 2014, 99 :77-87
[8]   Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies [J].
Antunes, Ana Rita Pombo ;
Scheyltjens, Isabelle ;
Duerinck, Johnny ;
Neyns, Bart ;
Movahedi, Kiavash ;
Van Ginderachter, Jo A. .
ELIFE, 2020, 9
[9]   Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer [J].
Ata, Rehman ;
Antonescu, Costin N. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
[10]  
Bababeygy SR, 2009, ANTICANCER RES, V29, P4901